Rang	Name	Position
1	Dr. Bassil I. Dahiyat Ph.D.	Co-Founder, CEO, President & Director
2	Mr. Bart Jan Cornelissen	Senior VP & CFO
3	Dr. John R. Desjarlais Ph.D.	Executive VP of Research & Chief Scientific Officer
4	Ms. Celia E. Eckert J.D.	Senior VP, General Counsel & Corporate Secretary
5	Mr. Charles Liles	Associate Director and Head of Corporate Communications & Investor Relations
6	Ms. Jennifer Sandoz	Senior VIce President of Human Resources
7	Mr. Kirk Rosemark RAC	Senior Vice President of Regulatory Affairs & Quality Assurance
8	Mr. Eric P. Kowack	Senior Vice President of Program Leadership & Alliance Management
9	Mr. Dane Vincent Leone C.F.A.	Executive VP & Chief Strategy Officer
10	Dr. Mark Osterman M.D.	Senior Vice President of Clinical Development (Autoimmune)

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	17,53%	0,32 Mrd. USD
2	PRIMECAP Management Company	13,69%	0,25 Mrd. USD
3	Bvf Inc	9,59%	0,17 Mrd. USD
4	RTW INVESTMENTS, LLC	9,12%	0,17 Mrd. USD
5	RA Capital Management, LLC	6,59%	0,12 Mrd. USD
6	State Street Corp	5,85%	0,11 Mrd. USD
7	Vanguard Portfolio Management, LLC	4,71%	0,09 Mrd. USD
8	Vanguard Capital Management, LLC	4,17%	0,08 Mrd. USD
9	TCG Crossover Management, LLC	3,30%	0,06 Mrd. USD
10	Geode Capital Management, LLC	2,44%	0,04 Mrd. USD
11	T. Rowe Price Associates, Inc.	2,10%	0,04 Mrd. USD
12	Morgan Stanley - Brokerage Accounts	2,10%	0,04 Mrd. USD
13	Baker Bros Advisors LP	1,48%	0,03 Mrd. USD
14	UBS Group AG	1,46%	0,03 Mrd. USD
15	Legal & General Group PLC	1,43%	0,03 Mrd. USD
16	Dimensional Fund Advisors, Inc.	1,36%	0,03 Mrd. USD
17	Millennium Management LLC	1,15%	0,02 Mrd. USD
18	Two Sigma Investments LLC	1,10%	0,02 Mrd. USD
19	The Goldman Sachs Group Inc	1,03%	0,02 Mrd. USD
20	Johnson & Johnson	1,01%	0,02 Mrd. USD